Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Anlin Hao"'
Autor:
Yousheng Mao, Shugeng Gao, Yin Li, Chun Chen, Anlin Hao, Qun Wang, Lijie Tan, Jianqun Ma, Gaoming Xiao, Xiangning Fu, Wentao Fang, Zhigang Li, Yongtao Han, Keneng Chen, Renquan Zhang, Xiaofei Li, Tiehua Rong, Jianhua Fu, Yongyu Liu, Weimin Mao, Meiqing Xu, Shuoyan Liu, Zhentao Yu, Zhirong Zhang, Yan Fang, Donghong Fu, Xudong Wei, Ligong Yuan, Shan Muhammad, Jie He
Publikováno v:
Journal of the National Cancer Center, Vol 3, Iss 2, Pp 106-114 (2023)
Background: Whether minimally invasive esophagectomy (MIE) is superior to open esophagectomy (OE) in the treatment of esophageal squamous cell carcinoma (ESCC) is still uncertain. Therefore, this multicenter prospective study aimed to compare MIE wit
Externí odkaz:
https://doaj.org/article/95874ac7b90240c98b31bb7dfa1fa30c
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 130, Iss , Pp 110490- (2020)
The multidrug resistance (MDR) which widely observed in multiple cancer types is responsible for the poor chemotherapy benefits of doxorubicin (Dox). Here in our study, Dox was firstly loaded into a scramble siRNA and then condensed by polyethyleneim
Externí odkaz:
https://doaj.org/article/5bafb98b279e42199bfc10e14d8ebac0
Autor:
Chenyu Wang, Linzhi Jin, Xinyu Cheng, Runchuan Ren, Anping Zheng, Anlin Hao, Nengchao Wang, Jinwen Zhang, Fuyou Zhou, Yaowen Zhang
Publikováno v:
BioMed Research International. 2022:1-9
This study is aimed at assessing the sintilimab-based regimens’ safety and efficacy for advanced esophageal cancer (EC) treatment in the real world. Cases of advanced EC treated with sintilimab-based regimens in the Anyang Tumor Hospital between 1
Autor:
Bo Yang, Xiaofeng Guo, Cheng Le, Wenzhong Su, Xiaoming Li, Yanfeng Zhang, Guangyi Yang, Weimin Liang, Zhixin Zheng, Junpeng Wu, Yaowen Zhang, Anlin Hao
Publikováno v:
BioMed Research International. 2022:1-9
Evidence for neoadjuvant chemotherapy combined with targeted therapy for locally advanced esophageal squamous cancer (ESCC) is inadequate. We conducted a single-arm phase II trial to evaluate the efficacy and safety of apatinib combined with taxol an
Autor:
Chenyu Wang, Xinyu Cheng, Linzhi Jin, Runchuan Ren, Shaohua Wang, Anping Zheng, Anlin Hao, Fuyou Zhou, Yaowen Zhang
Publikováno v:
BioMed Research International. 2022:1-8
This study aims to develop and validate a effective prognostic nomogram for locally advanced esophageal squamous cell carcinoma (LA-ESCC) patients undergoing concurrent chemoradiotherapy (CCRT). Retrospective analysis of 503 patients with LA-ESCC giv
Publikováno v:
Biochemical and Biophysical Research Communications. 519:497-504
Emerging evidence has uncovered the extremely important roles of long noncoding RNAs (lncRNAs) in the progression of malignant tumors which includes numerous processes of gene regulation. LncRNA NR2F1-AS1 has been confirmed to have close correlation
Publikováno v:
Functionalintegrative genomics. 21(3-4)
Esophageal carcinoma (EC) is a tremendous threat to human health and life worldwide. Long non-coding RNAs (lncRNAs) have been identified as crucial players in carcinomas including EC. An in-depth understanding on regulatory networks of lncRNAs contri